

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 9.81375583 |
| 2 | keratan sulfate catabolic process (GO:0042340) | 8.81314425 |
| 3 | cell aggregation (GO:0098743) | 8.50330326 |
| 4 | cartilage condensation (GO:0001502) | 8.50330326 |
| 5 | chondrocyte development (GO:0002063) | 7.86916144 |
| 6 | positive regulation of extracellular matrix organization (GO:1903055) | 6.28144230 |
| 7 | protein retention in ER lumen (GO:0006621) | 5.89819586 |
| 8 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.87787761 |
| 9 | notochord development (GO:0030903) | 5.58731519 |
| 10 | cellular glucuronidation (GO:0052695) | 5.58430273 |
| 11 | collagen fibril organization (GO:0030199) | 5.58357551 |
| 12 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 5.54351841 |
| 13 | limb bud formation (GO:0060174) | 5.24079555 |
| 14 | nucleotide-sugar biosynthetic process (GO:0009226) | 5.14380806 |
| 15 | uronic acid metabolic process (GO:0006063) | 5.09909902 |
| 16 | glucuronate metabolic process (GO:0019585) | 5.09909902 |
| 17 | COPII vesicle coating (GO:0048208) | 5.02423870 |
| 18 | COPI coating of Golgi vesicle (GO:0048205) | 4.92238852 |
| 19 | Golgi transport vesicle coating (GO:0048200) | 4.92238852 |
| 20 | cell adhesion mediated by integrin (GO:0033627) | 4.62569646 |
| 21 | regulation of extracellular matrix disassembly (GO:0010715) | 4.61741921 |
| 22 | regulation of plasminogen activation (GO:0010755) | 4.61709050 |
| 23 | hemidesmosome assembly (GO:0031581) | 4.55177923 |
| 24 | cartilage development (GO:0051216) | 4.45638424 |
| 25 | proteoglycan metabolic process (GO:0006029) | 4.39252541 |
| 26 | surfactant homeostasis (GO:0043129) | 4.38164490 |
| 27 | chondroitin sulfate biosynthetic process (GO:0030206) | 4.30215406 |
| 28 | embryonic skeletal joint morphogenesis (GO:0060272) | 4.23224368 |
| 29 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.11444933 |
| 30 | collagen catabolic process (GO:0030574) | 4.08865184 |
| 31 | desmosome organization (GO:0002934) | 4.04610049 |
| 32 | endochondral ossification (GO:0001958) | 3.99950234 |
| 33 | replacement ossification (GO:0036075) | 3.99950234 |
| 34 | endothelial cell morphogenesis (GO:0001886) | 3.95672553 |
| 35 | iron ion import (GO:0097286) | 3.93244760 |
| 36 | regulation of extracellular matrix organization (GO:1903053) | 3.91224652 |
| 37 | collagen metabolic process (GO:0032963) | 3.90568313 |
| 38 | keratan sulfate biosynthetic process (GO:0018146) | 3.87837728 |
| 39 | multicellular organismal catabolic process (GO:0044243) | 3.84879288 |
| 40 | negative regulation of complement activation (GO:0045916) | 3.82037025 |
| 41 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.66911354 |
| 42 | positive regulation of chondrocyte differentiation (GO:0032332) | 3.66794767 |
| 43 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.63814922 |
| 44 | negative regulation of gluconeogenesis (GO:0045721) | 3.60533349 |
| 45 | chemical homeostasis within a tissue (GO:0048875) | 3.59742817 |
| 46 | multicellular organismal metabolic process (GO:0044236) | 3.59092991 |
| 47 | chondrocyte differentiation (GO:0002062) | 3.58757340 |
| 48 | sulfur compound catabolic process (GO:0044273) | 3.56888661 |
| 49 | peptidyl-proline hydroxylation (GO:0019511) | 3.55941097 |
| 50 | skeletal system development (GO:0001501) | 3.51862039 |
| 51 | hypotonic response (GO:0006971) | 3.51841062 |
| 52 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.49020620 |
| 53 | keratan sulfate metabolic process (GO:0042339) | 3.48145103 |
| 54 | connective tissue development (GO:0061448) | 3.41631681 |
| 55 | negative regulation of protein activation cascade (GO:2000258) | 3.41098425 |
| 56 | skin morphogenesis (GO:0043589) | 3.39512650 |
| 57 | negative regulation of humoral immune response (GO:0002921) | 3.36577509 |
| 58 | 4-hydroxyproline metabolic process (GO:0019471) | 3.28671471 |
| 59 | membrane raft organization (GO:0031579) | 3.25760472 |
| 60 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.21608736 |
| 61 | positive regulation of cartilage development (GO:0061036) | 3.19916877 |
| 62 | nucleotide-sugar metabolic process (GO:0009225) | 3.19374945 |
| 63 | extracellular matrix disassembly (GO:0022617) | 3.16904157 |
| 64 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.15909175 |
| 65 | protein carboxylation (GO:0018214) | 3.15909175 |
| 66 | negative regulation of chemokine production (GO:0032682) | 3.09654467 |
| 67 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.08116978 |
| 68 | triglyceride homeostasis (GO:0070328) | 3.07721807 |
| 69 | acylglycerol homeostasis (GO:0055090) | 3.07721807 |
| 70 | protein localization to endosome (GO:0036010) | 3.07137798 |
| 71 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.06927824 |
| 72 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.06388236 |
| 73 | glycoprotein metabolic process (GO:0009100) | 2.98754703 |
| 74 | endodermal cell differentiation (GO:0035987) | 2.97724734 |
| 75 | sphingosine metabolic process (GO:0006670) | 2.94416227 |
| 76 | L-phenylalanine catabolic process (GO:0006559) | 2.94076299 |
| 77 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.94076299 |
| 78 | positive regulation of p38MAPK cascade (GO:1900745) | 2.93631374 |
| 79 | signal peptide processing (GO:0006465) | 2.93093354 |
| 80 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.86886486 |
| 81 | lipopolysaccharide metabolic process (GO:0008653) | 2.86870041 |
| 82 | myelin assembly (GO:0032288) | 2.84425871 |
| 83 | response to gravity (GO:0009629) | 2.84081611 |
| 84 | wound healing, spreading of epidermal cells (GO:0035313) | 2.82742968 |
| 85 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.80111047 |
| 86 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.80111047 |
| 87 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.79936032 |
| 88 | glycosaminoglycan catabolic process (GO:0006027) | 2.79652225 |
| 89 | negative regulation of fatty acid transport (GO:2000192) | 2.76931183 |
| 90 | endocardial cushion morphogenesis (GO:0003203) | 2.76848298 |
| 91 | cell-substrate junction assembly (GO:0007044) | 2.75395910 |
| 92 | cellular response to unfolded protein (GO:0034620) | 2.74086791 |
| 93 | glycosaminoglycan biosynthetic process (GO:0006024) | 2.74031204 |
| 94 | smooth muscle tissue development (GO:0048745) | 2.73945174 |
| 95 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.73632600 |
| 96 | type B pancreatic cell development (GO:0003323) | 2.72546650 |
| 97 | positive regulation of nuclease activity (GO:0032075) | 2.72471200 |
| 98 | epithelial cell-cell adhesion (GO:0090136) | 2.72228292 |
| 99 | diol metabolic process (GO:0034311) | 2.70837034 |
| 100 | aminoglycan biosynthetic process (GO:0006023) | 2.70583524 |
| 101 | regulation of metalloenzyme activity (GO:0048552) | 2.70403212 |
| 102 | macroautophagy (GO:0016236) | 2.70239962 |
| 103 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.70161264 |
| 104 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.69944900 |
| 105 | protein hydroxylation (GO:0018126) | 2.68990552 |
| 106 | ER-nucleus signaling pathway (GO:0006984) | 2.67991300 |
| 107 | aminoglycan catabolic process (GO:0006026) | 2.67881405 |
| 108 | diterpenoid biosynthetic process (GO:0016102) | 2.67775929 |
| 109 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.67244367 |
| 110 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.67244367 |
| 111 | cellular response to BMP stimulus (GO:0071773) | 2.66363585 |
| 112 | response to BMP (GO:0071772) | 2.66363585 |
| 113 | vesicle coating (GO:0006901) | 2.65094519 |
| 114 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.65078764 |
| 115 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.63472002 |
| 116 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.63404261 |
| 117 | regulation of cholesterol homeostasis (GO:2000188) | 2.62720792 |
| 118 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62196586 |
| 119 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.61999961 |
| 120 | aromatic amino acid family catabolic process (GO:0009074) | 2.61098609 |
| 121 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.60407771 |
| 122 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.59737542 |
| 123 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.57871191 |
| 124 | regulation of bone mineralization (GO:0030500) | 2.57418022 |
| 125 | uterus development (GO:0060065) | 2.56858924 |
| 126 | sphingoid metabolic process (GO:0046519) | 2.56594806 |
| 127 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.56043846 |
| 128 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.54747823 |
| 129 | L-phenylalanine metabolic process (GO:0006558) | 2.54747823 |
| 130 | chondrocyte proliferation (GO:0035988) | 2.53399198 |
| 131 | cellular response to topologically incorrect protein (GO:0035967) | 2.51084943 |
| 132 | ER overload response (GO:0006983) | 2.50976951 |
| 133 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.47843726 |
| 134 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.47346537 |
| 135 | regulation of water loss via skin (GO:0033561) | 2.47222598 |
| 136 | negative regulation of anoikis (GO:2000811) | 2.42817089 |
| 137 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.42568104 |
| 138 | mesodermal cell differentiation (GO:0048333) | 2.40535652 |
| 139 | apoptotic cell clearance (GO:0043277) | 2.38808971 |
| 140 | import into cell (GO:0098657) | 2.38544231 |
| 141 | multicellular organismal water homeostasis (GO:0050891) | 2.38115078 |
| 142 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.37819273 |
| 143 | keratinocyte proliferation (GO:0043616) | 2.37762484 |
| 144 | glomerular epithelial cell development (GO:0072310) | 2.36174434 |
| 145 | oligosaccharide catabolic process (GO:0009313) | 2.33936117 |
| 146 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.31890141 |
| 147 | intestinal epithelial cell development (GO:0060576) | 2.31184745 |
| 148 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.28941618 |
| 149 | axonemal dynein complex assembly (GO:0070286) | 2.27907291 |
| 150 | regulation of transforming growth factor beta production (GO:0071634) | 2.23557636 |
| 151 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.22780733 |
| 152 | fibril organization (GO:0097435) | 2.22667346 |
| 153 | wound healing, spreading of cells (GO:0044319) | 2.21871459 |
| 154 | positive regulation of osteoblast proliferation (GO:0033690) | 2.20971088 |
| 155 | * sphingomyelin metabolic process (GO:0006684) | 2.20234223 |
| 156 | regulation of phospholipase A2 activity (GO:0032429) | 2.19276207 |
| 157 | barbed-end actin filament capping (GO:0051016) | 2.18803833 |
| 158 | substrate-dependent cell migration (GO:0006929) | 2.17867988 |
| 159 | cellular response to vitamin D (GO:0071305) | 2.16339931 |
| 160 | stress fiber assembly (GO:0043149) | 2.16268990 |
| 161 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.14607043 |
| 162 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.14208620 |
| 163 | tight junction assembly (GO:0070830) | 2.13825776 |
| 164 | water homeostasis (GO:0030104) | 2.13502943 |
| 165 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.10373280 |
| 166 | regulation of p38MAPK cascade (GO:1900744) | 2.09439637 |
| 167 | peptide catabolic process (GO:0043171) | 2.09162174 |
| 168 | glycosphingolipid catabolic process (GO:0046479) | 2.07153073 |
| 169 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.06853835 |
| 170 | extracellular fibril organization (GO:0043206) | 2.06742718 |
| 171 | early endosome to late endosome transport (GO:0045022) | 2.06535107 |
| 172 | regulation of anoikis (GO:2000209) | 2.06080635 |
| 173 | glycolipid catabolic process (GO:0019377) | 2.06065365 |
| 174 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.05923181 |
| 175 | O-glycan processing (GO:0016266) | 2.05545562 |
| 176 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.05402214 |
| 177 | establishment of endothelial barrier (GO:0061028) | 2.04816042 |
| 178 | adhesion of symbiont to host cell (GO:0044650) | 2.04681469 |
| 179 | virion attachment to host cell (GO:0019062) | 2.04681469 |
| 180 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.04351191 |
| 181 | glomerular visceral epithelial cell development (GO:0072015) | 2.04102211 |
| 182 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.03663666 |
| 183 | positive regulation of cell junction assembly (GO:1901890) | 2.03243612 |
| 184 | positive regulation of focal adhesion assembly (GO:0051894) | 2.03243612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 7.50387804 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.95164764 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.42000114 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 4.12763522 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.59770531 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.41875723 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.10807324 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.10442962 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.74790299 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.69436971 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.40976936 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.38484097 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.32264627 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.29497577 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.28514860 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.27254064 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.21341766 |
| 18 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.16584167 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06723686 |
| 20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.05752186 |
| 21 | CJUN_26792858_Chip-Seq_BT549_Human | 2.03554350 |
| 22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.99752596 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98620291 |
| 24 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.93185901 |
| 25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.92753366 |
| 26 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.90158735 |
| 27 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.85129564 |
| 28 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.83013396 |
| 29 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.82433255 |
| 30 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.82433255 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76307587 |
| 32 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.76082918 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.74657572 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.73683727 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.70049717 |
| 36 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.69122641 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64466380 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.61065142 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59217801 |
| 40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.57859473 |
| 41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51197749 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48860397 |
| 43 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.48200544 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47203205 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45888340 |
| 46 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45115094 |
| 47 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.44913466 |
| 48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42386901 |
| 49 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.42056764 |
| 50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.39617335 |
| 51 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.39617335 |
| 52 | TP53_16413492_ChIP-PET_HCT116_Human | 1.38805706 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38769598 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37779851 |
| 55 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.36358720 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35895808 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35241547 |
| 58 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33474332 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32963327 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29529674 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.29509152 |
| 62 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.28110310 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.27274228 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25654671 |
| 65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25503960 |
| 66 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25244270 |
| 67 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24193806 |
| 68 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23027649 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.22542209 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20349864 |
| 71 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.18278723 |
| 72 | RXR_22108803_ChIP-Seq_LS180_Human | 1.15895041 |
| 73 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.15118136 |
| 74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14871352 |
| 75 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11099380 |
| 76 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11002353 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09223982 |
| 78 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.08535898 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08327106 |
| 80 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.07069943 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06588966 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05161896 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05118982 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04821909 |
| 85 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03320540 |
| 86 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02257375 |
| 87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01042112 |
| 88 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00883063 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00363469 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99728323 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99013391 |
| 92 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98408652 |
| 93 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.97870866 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97763085 |
| 95 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.97427085 |
| 96 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96346500 |
| 97 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95578474 |
| 98 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95189445 |
| 99 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.94426471 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94218879 |
| 101 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92493440 |
| 102 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.92402478 |
| 103 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90660646 |
| 104 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90638096 |
| 105 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.88909884 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88579662 |
| 107 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88399043 |
| 108 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.87927421 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86526103 |
| 110 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.86492595 |
| 111 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.86184398 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85444228 |
| 113 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85407908 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83394217 |
| 115 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.82547567 |
| 116 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80792021 |
| 117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80792021 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.80703928 |
| 119 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.80169927 |
| 120 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79366756 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79297479 |
| 122 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78129163 |
| 123 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76463319 |
| 124 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75981530 |
| 125 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.75104201 |
| 126 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.74873552 |
| 127 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.74129139 |
| 128 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.73205768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002933_joint_inflammation | 5.01036059 |
| 2 | MP0004134_abnormal_chest_morphology | 4.16740950 |
| 3 | MP0002282_abnormal_trachea_morphology | 4.12049272 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.98912435 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.80170719 |
| 6 | MP0000163_abnormal_cartilage_morphology | 3.57894400 |
| 7 | MP0005503_abnormal_tendon_morphology | 3.48530622 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 3.36189299 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 3.34115288 |
| 10 | MP0003950_abnormal_plasma_membrane | 3.16712879 |
| 11 | MP0009250_abnormal_appendicular_skeleto | 3.09040835 |
| 12 | MP0002115_abnormal_skeleton_extremities | 3.01096268 |
| 13 | MP0002896_abnormal_bone_mineralization | 2.82211998 |
| 14 | MP0001533_abnormal_skeleton_physiology | 2.63382177 |
| 15 | MP0003195_calcinosis | 2.62532257 |
| 16 | MP0003646_muscle_fatigue | 2.55931294 |
| 17 | MP0005360_urolithiasis | 2.48373188 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.47698926 |
| 19 | MP0002113_abnormal_skeleton_development | 2.43839843 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.42484651 |
| 21 | MP0003283_abnormal_digestive_organ | 2.37928705 |
| 22 | MP0002089_abnormal_postnatal_growth/wei | 2.32794479 |
| 23 | MP0001542_abnormal_bone_strength | 2.21807029 |
| 24 | MP0005390_skeleton_phenotype | 2.20868664 |
| 25 | MP0010678_abnormal_skin_adnexa | 2.04614886 |
| 26 | MP0004782_abnormal_surfactant_physiolog | 2.04594632 |
| 27 | MP0003795_abnormal_bone_structure | 2.00467906 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.97498750 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 1.96875684 |
| 30 | MP0005365_abnormal_bile_salt | 1.96097259 |
| 31 | MP0009840_abnormal_foam_cell | 1.94552031 |
| 32 | MP0003123_paternal_imprinting | 1.92679808 |
| 33 | MP0003436_decreased_susceptibility_to | 1.91390685 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.90744812 |
| 35 | MP0005508_abnormal_skeleton_morphology | 1.90311330 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.84594662 |
| 37 | MP0008004_abnormal_stomach_pH | 1.84181948 |
| 38 | MP0001299_abnormal_eye_distance/ | 1.83957918 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.83100998 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.81814295 |
| 41 | MP0001270_distended_abdomen | 1.81386179 |
| 42 | MP0002163_abnormal_gland_morphology | 1.79199580 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.75532911 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.72579167 |
| 45 | MP0000762_abnormal_tongue_morphology | 1.69314318 |
| 46 | MP0002109_abnormal_limb_morphology | 1.68885821 |
| 47 | MP0003941_abnormal_skin_development | 1.65433604 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.64575245 |
| 49 | MP0002796_impaired_skin_barrier | 1.58878408 |
| 50 | MP0003252_abnormal_bile_duct | 1.52130952 |
| 51 | MP0003828_pulmonary_edema | 1.51120203 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.49058112 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.47738982 |
| 54 | MP0006054_spinal_hemorrhage | 1.46688260 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.40981625 |
| 56 | MP0005165_increased_susceptibility_to | 1.36985727 |
| 57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.36515479 |
| 58 | MP0000383_abnormal_hair_follicle | 1.34256230 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.34165008 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 1.34150683 |
| 61 | MP0003045_fibrosis | 1.31264033 |
| 62 | MP0000343_altered_response_to | 1.30822748 |
| 63 | MP0002168_other_aberrant_phenotype | 1.26250239 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.22982118 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.22386003 |
| 66 | MP0001663_abnormal_digestive_system | 1.20921355 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.19806445 |
| 68 | MP0002295_abnormal_pulmonary_circulatio | 1.19503625 |
| 69 | MP0006082_CNS_inflammation | 1.19268681 |
| 70 | MP0009697_abnormal_copulation | 1.18895321 |
| 71 | MP0005381_digestive/alimentary_phenotyp | 1.18698086 |
| 72 | MP0005164_abnormal_response_to | 1.18333509 |
| 73 | MP0003724_increased_susceptibility_to | 1.17892892 |
| 74 | MP0001216_abnormal_epidermal_layer | 1.17070498 |
| 75 | MP0005023_abnormal_wound_healing | 1.15207146 |
| 76 | MP0005275_abnormal_skin_tensile | 1.14925084 |
| 77 | MP0004947_skin_inflammation | 1.14384717 |
| 78 | MP0002332_abnormal_exercise_endurance | 1.13605780 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 1.11331131 |
| 80 | MP0004883_abnormal_blood_vessel | 1.06467265 |
| 81 | MP0004272_abnormal_basement_membrane | 1.05201362 |
| 82 | MP0002116_abnormal_craniofacial_bone | 1.05035947 |
| 83 | MP0010386_abnormal_urinary_bladder | 1.04084781 |
| 84 | MP0003868_abnormal_feces_composition | 1.03166250 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 1.02882801 |
| 86 | MP0003183_abnormal_peptide_metabolism | 1.01337547 |
| 87 | MP0010329_abnormal_lipoprotein_level | 0.98556880 |
| 88 | MP0005409_darkened_coat_color | 0.96688615 |
| 89 | MP0002108_abnormal_muscle_morphology | 0.96558896 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.96438586 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.95621029 |
| 92 | MP0005332_abnormal_amino_acid | 0.95620894 |
| 93 | MP0001666_abnormal_nutrient_absorption | 0.94294749 |
| 94 | MP0003755_abnormal_palate_morphology | 0.94278998 |
| 95 | MP0004510_myositis | 0.93968106 |
| 96 | MP0003279_aneurysm | 0.93784067 |
| 97 | MP0005501_abnormal_skin_physiology | 0.92583995 |
| 98 | MP0003303_peritoneal_inflammation | 0.91970280 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.86951107 |
| 100 | MP0005388_respiratory_system_phenotype | 0.86776998 |
| 101 | MP0002133_abnormal_respiratory_system | 0.86776998 |
| 102 | MP0000432_abnormal_head_morphology | 0.86519000 |
| 103 | MP0003448_altered_tumor_morphology | 0.86104885 |
| 104 | MP0000462_abnormal_digestive_system | 0.85930924 |
| 105 | MP0001879_abnormal_lymphatic_vessel | 0.84164588 |
| 106 | MP0010771_integument_phenotype | 0.83816674 |
| 107 | MP0000858_altered_metastatic_potential | 0.81051944 |
| 108 | MP0001851_eye_inflammation | 0.80801874 |
| 109 | MP0000249_abnormal_blood_vessel | 0.80416822 |
| 110 | MP0000049_abnormal_middle_ear | 0.79510986 |
| 111 | MP0005083_abnormal_biliary_tract | 0.78529359 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.77559872 |
| 113 | MP0005395_other_phenotype | 0.77499211 |
| 114 | MP0004019_abnormal_vitamin_homeostasis | 0.75791424 |
| 115 | MP0001958_emphysema | 0.75406674 |
| 116 | MP0005166_decreased_susceptibility_to | 0.74992880 |
| 117 | MP0003787_abnormal_imprinting | 0.74507598 |
| 118 | MP0005451_abnormal_body_composition | 0.74311414 |
| 119 | MP0004484_altered_response_of | 0.73528326 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.73455338 |
| 121 | MP0000467_abnormal_esophagus_morphology | 0.72720877 |
| 122 | MP0000733_abnormal_muscle_development | 0.72360572 |
| 123 | MP0003186_abnormal_redox_activity | 0.72179789 |
| 124 | MP0002111_abnormal_tail_morphology | 0.71851543 |
| 125 | MP0001944_abnormal_pancreas_morphology | 0.71380189 |
| 126 | MP0001764_abnormal_homeostasis | 0.70796681 |
| 127 | MP0002006_tumorigenesis | 0.70382564 |
| 128 | MP0005076_abnormal_cell_differentiation | 0.69519550 |
| 129 | MP0004084_abnormal_cardiac_muscle | 0.68536164 |
| 130 | MP0003075_altered_response_to | 0.67710750 |
| 131 | MP0010155_abnormal_intestine_physiology | 0.67709425 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.67408657 |
| 133 | MP0003300_gastrointestinal_ulcer | 0.66704743 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.66444516 |
| 135 | MP0003935_abnormal_craniofacial_develop | 0.65967258 |
| 136 | MP0002060_abnormal_skin_morphology | 0.65670295 |
| 137 | MP0002166_altered_tumor_susceptibility | 0.65611650 |
| 138 | MP0002971_abnormal_brown_adipose | 0.65545223 |
| 139 | MP0000627_abnormal_mammary_gland | 0.64247402 |
| 140 | MP0004043_abnormal_pH_regulation | 0.64031546 |
| 141 | MP0005636_abnormal_mineral_homeostasis | 0.62437971 |
| 142 | MP0000465_gastrointestinal_hemorrhage | 0.62392483 |
| 143 | MP0003091_abnormal_cell_migration | 0.58223811 |
| 144 | MP0001243_abnormal_dermal_layer | 0.58170076 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.57770698 |
| 146 | MP0000538_abnormal_urinary_bladder | 0.57063468 |
| 147 | * MP0002118_abnormal_lipid_homeostasis | 0.57002870 |
| 148 | MP0009764_decreased_sensitivity_to | 0.56227831 |
| 149 | MP0002233_abnormal_nose_morphology | 0.55751952 |
| 150 | MP0002114_abnormal_axial_skeleton | 0.55190056 |
| 151 | MP0004264_abnormal_extraembryonic_tissu | 0.55048255 |
| 152 | MP0004197_abnormal_fetal_growth/weight/ | 0.54916620 |
| 153 | * MP0000609_abnormal_liver_physiology | 0.54575642 |
| 154 | MP0001756_abnormal_urination | 0.50429114 |
| 155 | MP0001873_stomach_inflammation | 0.49742113 |
| 156 | * MP0002419_abnormal_innate_immunity | 0.48956695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Epiphyseal dysplasia (HP:0002656) | 9.43200131 |
| 2 | Irregular epiphyses (HP:0010582) | 8.80643840 |
| 3 | Vitreoretinal degeneration (HP:0000655) | 7.52363703 |
| 4 | Abnormal tarsal ossification (HP:0008369) | 6.59263756 |
| 5 | Cupped ribs (HP:0000887) | 6.51137804 |
| 6 | Hypoplastic ischia (HP:0003175) | 6.31092036 |
| 7 | Small epiphyses (HP:0010585) | 6.26029994 |
| 8 | Abnormality of the ischium (HP:0003174) | 5.65451797 |
| 9 | Flat acetabular roof (HP:0003180) | 5.33465579 |
| 10 | Delayed epiphyseal ossification (HP:0002663) | 5.23335895 |
| 11 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 5.21358474 |
| 12 | Flat capital femoral epiphysis (HP:0003370) | 5.06497228 |
| 13 | Abnormal foot bone ossification (HP:0010675) | 5.05934371 |
| 14 | Metaphyseal cupping (HP:0003021) | 5.03742098 |
| 15 | Genu varum (HP:0002970) | 4.91941070 |
| 16 | Abnormality of the vertebral endplates (HP:0005106) | 4.47793385 |
| 17 | Abnormality of femoral epiphyses (HP:0006499) | 4.35897069 |
| 18 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 4.35897069 |
| 19 | Arthropathy (HP:0003040) | 4.35415006 |
| 20 | Flattened epiphyses (HP:0003071) | 4.29906945 |
| 21 | Metaphyseal dysplasia (HP:0100255) | 4.29175744 |
| 22 | Premature rupture of membranes (HP:0001788) | 4.05998572 |
| 23 | Neonatal short-limb short stature (HP:0008921) | 4.04893474 |
| 24 | Metaphyseal irregularity (HP:0003025) | 4.02964150 |
| 25 | Absent epiphyses (HP:0010577) | 4.00203917 |
| 26 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 4.00203917 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 3.97163229 |
| 28 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 3.90426042 |
| 29 | Irregular vertebral endplates (HP:0003301) | 3.89445821 |
| 30 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.88273181 |
| 31 | Osteolytic defects of the hand bones (HP:0009699) | 3.88273181 |
| 32 | Short femoral neck (HP:0100864) | 3.85051883 |
| 33 | Osteoarthritis (HP:0002758) | 3.84072521 |
| 34 | Mild short stature (HP:0003502) | 3.79299237 |
| 35 | Cardiovascular calcification (HP:0011915) | 3.74434953 |
| 36 | Protuberant abdomen (HP:0001538) | 3.66770091 |
| 37 | Protrusio acetabuli (HP:0003179) | 3.62808490 |
| 38 | Abnormality of the femoral head (HP:0003368) | 3.60990576 |
| 39 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 3.52969440 |
| 40 | Atrophic scars (HP:0001075) | 3.41718626 |
| 41 | Right ventricular cardiomyopathy (HP:0011663) | 3.41450820 |
| 42 | Enlarged epiphyses (HP:0010580) | 3.40514033 |
| 43 | Vascular calcification (HP:0004934) | 3.32518961 |
| 44 | Abnormality of carpal bone ossification (HP:0006257) | 3.28913009 |
| 45 | Coxa vara (HP:0002812) | 3.27918939 |
| 46 | Arterial tortuosity (HP:0005116) | 3.26284969 |
| 47 | Aortic aneurysm (HP:0004942) | 3.26037738 |
| 48 | Vascular tortuosity (HP:0004948) | 3.25531224 |
| 49 | Aortic dissection (HP:0002647) | 3.24763581 |
| 50 | Mitral stenosis (HP:0001718) | 3.22614241 |
| 51 | Ovoid vertebral bodies (HP:0003300) | 3.18804910 |
| 52 | Thoracolumbar scoliosis (HP:0002944) | 3.18547475 |
| 53 | Cervical subluxation (HP:0003308) | 3.18014158 |
| 54 | Beaking of vertebral bodies (HP:0004568) | 3.14954453 |
| 55 | Platyspondyly (HP:0000926) | 3.12587202 |
| 56 | Short nail (HP:0001799) | 3.07204526 |
| 57 | Abnormal vertebral ossification (HP:0100569) | 3.07026361 |
| 58 | Abnormality of the pubic bones (HP:0003172) | 2.88179062 |
| 59 | Malnutrition (HP:0004395) | 2.86610244 |
| 60 | Stillbirth (HP:0003826) | 2.83838444 |
| 61 | Absent frontal sinuses (HP:0002688) | 2.82783299 |
| 62 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.81991470 |
| 63 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.80245148 |
| 64 | Barrel-shaped chest (HP:0001552) | 2.71935764 |
| 65 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.68110987 |
| 66 | Waddling gait (HP:0002515) | 2.67704217 |
| 67 | Vertebral clefting (HP:0008428) | 2.66497470 |
| 68 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.62668599 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.62478849 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.62478849 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.62478849 |
| 72 | Spondylolisthesis (HP:0003302) | 2.61411753 |
| 73 | Abnormal hand bone ossification (HP:0010660) | 2.60903107 |
| 74 | Limited elbow extension (HP:0001377) | 2.59358149 |
| 75 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.56804707 |
| 76 | Abnormality of incisor morphology (HP:0011063) | 2.55380249 |
| 77 | Abnormal ossification of hand bones (HP:0005921) | 2.50033996 |
| 78 | Hypoplasia of the odontoid process (HP:0003311) | 2.48913526 |
| 79 | Tetraparesis (HP:0002273) | 2.48146323 |
| 80 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.44123394 |
| 81 | Fragile skin (HP:0001030) | 2.43877947 |
| 82 | Alopecia of scalp (HP:0002293) | 2.43141563 |
| 83 | Wormian bones (HP:0002645) | 2.42826569 |
| 84 | Thin ribs (HP:0000883) | 2.42167487 |
| 85 | Abnormality of the lumbar spine (HP:0100712) | 2.41486692 |
| 86 | Long clavicles (HP:0000890) | 2.40563151 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.40171413 |
| 88 | Mucopolysacchariduria (HP:0008155) | 2.40171413 |
| 89 | Abnormality of the vitreous humor (HP:0004327) | 2.38173626 |
| 90 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.37917254 |
| 91 | Disproportionate short-trunk short stature (HP:0003521) | 2.37528414 |
| 92 | Vertebral compression fractures (HP:0002953) | 2.37011213 |
| 93 | Lumbar hyperlordosis (HP:0002938) | 2.31909356 |
| 94 | Rhinitis (HP:0012384) | 2.31508140 |
| 95 | Carpal bone hypoplasia (HP:0001498) | 2.31253740 |
| 96 | Distal lower limb muscle weakness (HP:0009053) | 2.30772379 |
| 97 | Increased CSF protein (HP:0002922) | 2.28611838 |
| 98 | Exostoses (HP:0100777) | 2.27420216 |
| 99 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26359116 |
| 100 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26359116 |
| 101 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26359116 |
| 102 | Limited hip movement (HP:0008800) | 2.25154720 |
| 103 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.25152969 |
| 104 | Striae distensae (HP:0001065) | 2.23643683 |
| 105 | Fibular hypoplasia (HP:0003038) | 2.23311633 |
| 106 | Spinal cord compression (HP:0002176) | 2.23162836 |
| 107 | Hyperactive renin-angiotensin system (HP:0000841) | 2.22225146 |
| 108 | Follicular hyperkeratosis (HP:0007502) | 2.21558988 |
| 109 | Overgrowth (HP:0001548) | 2.19512987 |
| 110 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.18078268 |
| 111 | Vertebral hypoplasia (HP:0008417) | 2.18078268 |
| 112 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.12303531 |
| 113 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.11710418 |
| 114 | Abnormality of the acetabulum (HP:0003170) | 2.11309215 |
| 115 | Dilatation of the ascending aorta (HP:0005111) | 2.10566745 |
| 116 | Glossoptosis (HP:0000162) | 2.08247013 |
| 117 | Fat malabsorption (HP:0002630) | 2.07482758 |
| 118 | Milia (HP:0001056) | 2.07326856 |
| 119 | Abnormality of the odontoid process (HP:0003310) | 2.07232002 |
| 120 | Micromelia (HP:0002983) | 2.06859304 |
| 121 | Hypoplastic ilia (HP:0000946) | 2.06653542 |
| 122 | Glucose intolerance (HP:0000833) | 2.06541033 |
| 123 | Thick nail (HP:0001805) | 2.05948945 |
| 124 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.04228008 |
| 125 | Abnormal ciliary motility (HP:0012262) | 2.03815394 |
| 126 | Hip contracture (HP:0003273) | 2.03197857 |
| 127 | Radial bowing (HP:0002986) | 2.03064727 |
| 128 | Steatorrhea (HP:0002570) | 2.02278394 |
| 129 | Aneurysm (HP:0002617) | 2.02229979 |
| 130 | Ulnar bowing (HP:0003031) | 2.01538627 |
| 131 | Hyporeflexia of lower limbs (HP:0002600) | 1.98816208 |
| 132 | Abnormality of the 2nd finger (HP:0004100) | 1.97931322 |
| 133 | Onycholysis (HP:0001806) | 1.96798032 |
| 134 | Dysostosis multiplex (HP:0000943) | 1.95796850 |
| 135 | Abnormality of the frontal sinuses (HP:0002687) | 1.95334366 |
| 136 | Subacute progressive viral hepatitis (HP:0006572) | 1.94719398 |
| 137 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.94443432 |
| 138 | Amyloidosis (HP:0011034) | 1.93970882 |
| 139 | Plantar hyperkeratosis (HP:0007556) | 1.93952625 |
| 140 | Asymmetric septal hypertrophy (HP:0001670) | 1.93216307 |
| 141 | Cerebral aneurysm (HP:0004944) | 1.92497533 |
| 142 | Mesomelia (HP:0003027) | 1.92348375 |
| 143 | Absent/shortened dynein arms (HP:0200106) | 1.91323356 |
| 144 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.91323356 |
| 145 | Abnormal glucose tolerance (HP:0001952) | 1.89310737 |
| 146 | Increased connective tissue (HP:0009025) | 1.88637082 |
| 147 | Aplasia/Hypoplasia involving the vertebral column (HP:0008518) | 1.88121026 |
| 148 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.87803092 |
| 149 | Natal tooth (HP:0000695) | 1.87676176 |
| 150 | Hypoplasia of dental enamel (HP:0006297) | 1.87476835 |
| 151 | Myocardial infarction (HP:0001658) | 1.87044312 |
| 152 | Abnormal cartilage morphology (HP:0002763) | 1.86809908 |
| 153 | Abdominal distention (HP:0003270) | 1.84797711 |
| 154 | Conjugated hyperbilirubinemia (HP:0002908) | 1.84220361 |
| 155 | Abnormality of the nasal mucosa (HP:0000433) | 1.83929792 |
| 156 | Spinal rigidity (HP:0003306) | 1.83127440 |
| 157 | Short middle phalanx of finger (HP:0005819) | 1.82389918 |
| 158 | Coxa valga (HP:0002673) | 1.80357364 |
| 159 | Chronic bronchitis (HP:0004469) | 1.79598416 |
| 160 | Flared metaphyses (HP:0003015) | 1.78673942 |
| 161 | Joint stiffness (HP:0001387) | 1.78358814 |
| 162 | Popliteal pterygium (HP:0009756) | 1.77836492 |
| 163 | Intrahepatic cholestasis (HP:0001406) | 1.76130679 |
| 164 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.75730508 |
| 165 | Rhizomelia (HP:0008905) | 1.75182391 |
| 166 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.75050122 |
| 167 | Hypoplastic scapulae (HP:0000882) | 1.74945588 |
| 168 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.74945588 |
| 169 | Hypoplastic pelvis (HP:0008839) | 1.74875020 |
| 170 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.74855768 |
| 171 | Hydroxyprolinuria (HP:0003080) | 1.73893693 |
| 172 | Abnormality of proline metabolism (HP:0010907) | 1.73893693 |
| 173 | Periodontitis (HP:0000704) | 1.73019966 |
| 174 | Mitral valve prolapse (HP:0001634) | 1.72783261 |
| 175 | Loss of speech (HP:0002371) | 1.72519733 |
| 176 | Broad phalanx (HP:0006009) | 1.72203335 |
| 177 | Patent foramen ovale (HP:0001655) | 1.70920398 |
| 178 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.70659531 |
| 179 | Nuclear cataract (HP:0100018) | 1.70403770 |
| 180 | Soft skin (HP:0000977) | 1.70367961 |
| 181 | Tibial bowing (HP:0002982) | 1.70283185 |
| 182 | Thin bony cortex (HP:0002753) | 1.69435516 |
| 183 | Hoarse voice (HP:0001609) | 1.69358248 |
| 184 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.69170866 |
| 185 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.69170866 |
| 186 | Papillary thyroid carcinoma (HP:0002895) | 1.68506273 |
| 187 | Femoral bowing (HP:0002980) | 1.66387183 |
| 188 | Skin nodule (HP:0200036) | 1.64326405 |
| 189 | Hematochezia (HP:0002573) | 1.62741491 |
| 190 | Ankle contracture (HP:0006466) | 1.62284905 |
| 191 | Distal lower limb amyotrophy (HP:0008944) | 1.61963802 |
| 192 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.61665593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K3 | 6.56510864 |
| 2 | DDR2 | 5.73824588 |
| 3 | STK38L | 4.48759943 |
| 4 | STK24 | 3.86696230 |
| 5 | PRKG2 | 3.41987349 |
| 6 | NME1 | 3.11328439 |
| 7 | MST4 | 2.56154316 |
| 8 | RIPK1 | 2.38862323 |
| 9 | LATS1 | 2.32841356 |
| 10 | MYLK | 2.30469653 |
| 11 | ERBB3 | 2.16757178 |
| 12 | FRK | 2.12127345 |
| 13 | NUAK1 | 2.06342699 |
| 14 | TAOK3 | 1.87380361 |
| 15 | TTN | 1.73037375 |
| 16 | EIF2AK3 | 1.69560602 |
| 17 | STK3 | 1.68949991 |
| 18 | MAP3K12 | 1.68858926 |
| 19 | TRPM7 | 1.66830663 |
| 20 | WNK4 | 1.65649160 |
| 21 | TESK1 | 1.64566608 |
| 22 | LATS2 | 1.62035701 |
| 23 | EPHA2 | 1.54586585 |
| 24 | ERN1 | 1.51726585 |
| 25 | PDGFRA | 1.49804937 |
| 26 | INSRR | 1.44547250 |
| 27 | LMTK2 | 1.38259428 |
| 28 | MOS | 1.37917853 |
| 29 | SIK1 | 1.36319962 |
| 30 | STK38 | 1.35906143 |
| 31 | MET | 1.32664954 |
| 32 | PAK4 | 1.25033433 |
| 33 | PIM2 | 1.24909529 |
| 34 | MST1R | 1.22197849 |
| 35 | EPHB1 | 1.19416170 |
| 36 | PIK3CG | 1.14098439 |
| 37 | MAP2K3 | 1.11243305 |
| 38 | TRIB3 | 1.09440098 |
| 39 | MAP3K14 | 1.08187380 |
| 40 | WNK3 | 1.05347675 |
| 41 | PDGFRB | 1.04956348 |
| 42 | DMPK | 0.96573903 |
| 43 | DYRK1A | 0.95687140 |
| 44 | MAPK15 | 0.95195449 |
| 45 | GSK3A | 0.93509859 |
| 46 | PLK2 | 0.93144702 |
| 47 | ARAF | 0.91848289 |
| 48 | TAOK1 | 0.91566918 |
| 49 | CDC42BPA | 0.91198312 |
| 50 | PDK2 | 0.89597620 |
| 51 | MAP3K6 | 0.89441790 |
| 52 | PIK3CA | 0.88064005 |
| 53 | MAP3K13 | 0.87374293 |
| 54 | MAP3K9 | 0.87215929 |
| 55 | MAP3K1 | 0.87019582 |
| 56 | IRAK4 | 0.85564114 |
| 57 | AKT3 | 0.84399422 |
| 58 | PRKD3 | 0.84362382 |
| 59 | BRSK2 | 0.82543624 |
| 60 | NEK9 | 0.82444672 |
| 61 | MAPK4 | 0.80439461 |
| 62 | LIMK1 | 0.80019964 |
| 63 | IRAK1 | 0.79864786 |
| 64 | PRPF4B | 0.78537655 |
| 65 | GRK7 | 0.77477635 |
| 66 | PTK2 | 0.77460864 |
| 67 | EPHA3 | 0.72867800 |
| 68 | MKNK2 | 0.71864102 |
| 69 | NEK6 | 0.70440253 |
| 70 | PAK2 | 0.69102774 |
| 71 | FLT3 | 0.69036288 |
| 72 | CAMKK2 | 0.67182520 |
| 73 | ZAP70 | 0.67161039 |
| 74 | FGFR3 | 0.64805764 |
| 75 | ERBB4 | 0.64339405 |
| 76 | IRAK3 | 0.63637396 |
| 77 | TYK2 | 0.63529314 |
| 78 | MAPK12 | 0.63422148 |
| 79 | NLK | 0.62314464 |
| 80 | CDK12 | 0.61572012 |
| 81 | PBK | 0.60539106 |
| 82 | BCKDK | 0.59851824 |
| 83 | ICK | 0.59757825 |
| 84 | TAOK2 | 0.59682053 |
| 85 | MAPK7 | 0.59262840 |
| 86 | PTK6 | 0.59012401 |
| 87 | ACVR1B | 0.58922150 |
| 88 | ROCK1 | 0.58292375 |
| 89 | SCYL2 | 0.57279224 |
| 90 | PDPK1 | 0.56935233 |
| 91 | PIM1 | 0.56927662 |
| 92 | CSK | 0.55923730 |
| 93 | WNK1 | 0.55702558 |
| 94 | PRKAA2 | 0.55579483 |
| 95 | IRAK2 | 0.54524041 |
| 96 | FGFR4 | 0.53074484 |
| 97 | MTOR | 0.50646911 |
| 98 | JAK1 | 0.48910627 |
| 99 | PASK | 0.48635592 |
| 100 | TEC | 0.48502391 |
| 101 | SGK3 | 0.47864560 |
| 102 | PRKD2 | 0.47771008 |
| 103 | MAPKAPK3 | 0.46313633 |
| 104 | KSR2 | 0.46061848 |
| 105 | PKN2 | 0.45579034 |
| 106 | RPS6KA2 | 0.44670493 |
| 107 | EIF2AK1 | 0.44192506 |
| 108 | STK10 | 0.43913792 |
| 109 | STK39 | 0.43722615 |
| 110 | SGK2 | 0.43180317 |
| 111 | BCR | 0.42154561 |
| 112 | PRKCE | 0.41452069 |
| 113 | YES1 | 0.41151313 |
| 114 | RPS6KB1 | 0.38641990 |
| 115 | ROCK2 | 0.38256743 |
| 116 | TGFBR2 | 0.38218117 |
| 117 | MAP3K5 | 0.38138947 |
| 118 | MAP2K1 | 0.36897680 |
| 119 | CHUK | 0.36366686 |
| 120 | PRKCD | 0.35038835 |
| 121 | ABL2 | 0.34612534 |
| 122 | PRKACG | 0.34566596 |
| 123 | MAP3K2 | 0.33809766 |
| 124 | EPHB2 | 0.33633543 |
| 125 | TBK1 | 0.33068790 |
| 126 | MUSK | 0.31974727 |
| 127 | IGF1R | 0.31608504 |
| 128 | PTK2B | 0.31542150 |
| 129 | BMPR1B | 0.30953362 |
| 130 | LRRK2 | 0.30633597 |
| 131 | ABL1 | 0.28943306 |
| 132 | NME2 | 0.28731069 |
| 133 | FER | 0.26293812 |
| 134 | BMPR2 | 0.25105481 |
| 135 | IKBKB | 0.24910994 |
| 136 | RPS6KA4 | 0.24487633 |
| 137 | MAP3K11 | 0.23946536 |
| 138 | MARK3 | 0.23768378 |
| 139 | MELK | 0.23276380 |
| 140 | PRKCI | 0.23146698 |
| 141 | MAPK3 | 0.22568252 |
| 142 | EIF2AK2 | 0.21876943 |
| 143 | PRKG1 | 0.21446093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 4.92527783 |
| 2 | Protein digestion and absorption_Homo sapiens_hsa04974 | 4.03076001 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.82723841 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.50996508 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15162898 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.77379941 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.57923209 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.54882015 |
| 9 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.52799727 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.28112529 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.24203047 |
| 12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.22636067 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.13685517 |
| 14 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.08440659 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.97186107 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81591429 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74846618 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.71934631 |
| 19 | Adherens junction_Homo sapiens_hsa04520 | 1.57711764 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.48865274 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.46858829 |
| 22 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.39700872 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.38932503 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37620865 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37107189 |
| 26 | Focal adhesion_Homo sapiens_hsa04510 | 1.32944630 |
| 27 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.26880971 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.22100221 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18226970 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17321272 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16180121 |
| 32 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16113016 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.15009672 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14531817 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.14175707 |
| 36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14010654 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.13069791 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12114063 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10931633 |
| 40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10458622 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10063333 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08066422 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06121988 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.05995013 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.05664885 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.05014464 |
| 47 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00983952 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.00574962 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.98212405 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97642502 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.97009671 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.96464587 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95465507 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94946748 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 0.94705680 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93240358 |
| 57 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.92054707 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 0.91290316 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.91173342 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90461414 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89766043 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88286281 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86994180 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.85963335 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83547071 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82998172 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80946037 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.80846560 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.80413884 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79605327 |
| 71 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.77165369 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76232225 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76062681 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75809949 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75356885 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72108833 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70556777 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.70457216 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69375027 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69312934 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69243172 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67510694 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66647573 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66331261 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65605071 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65516434 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65093104 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.64931441 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64390068 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63493038 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62822091 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.62657810 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62599296 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.61721710 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61137175 |
| 96 | Influenza A_Homo sapiens_hsa05164 | 0.60951227 |
| 97 | Tuberculosis_Homo sapiens_hsa05152 | 0.60635100 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60256922 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59452130 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59429309 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58844861 |
| 102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58037879 |
| 103 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57116295 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.56666573 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55558655 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54177062 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52769323 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50477382 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50413994 |
| 110 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50233222 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.49869438 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48529819 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48330125 |
| 114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47891602 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46882751 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46505470 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45978840 |
| 118 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45463617 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44110208 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.43955217 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42749132 |
| 122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42394328 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42354388 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.41798434 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41580553 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.41406337 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38794989 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.36049792 |
| 129 | Leishmaniasis_Homo sapiens_hsa05140 | 0.35997726 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34577351 |
| 131 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34271246 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.33746950 |
| 133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33269043 |
| 134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32905373 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31428869 |
| 136 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.30138952 |
| 137 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.27132282 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.22433290 |
| 139 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19189064 |
| 140 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17109900 |
| 141 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.16696492 |
| 142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15644209 |
| 143 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.13884808 |
| 144 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.12820083 |
| 145 | Olfactory transduction_Homo sapiens_hsa04740 | 0.11833298 |

